Loading…
Validated market sizing, competitive landscapes, and growth forecasts. Cross-referenced from 26 primary data sources. Toggle density view for a terminal-style browse.
The global inpatient services market sat at $2,090B at year-end 2024, covering hospital-based acute care, surgical procedures, and specialty treatment facilities. The market is projected to reach $3,006B by 2036, compounding at 3.7% annually per Grand View Research and Fortune Business Insights data published in 2025.
The global preventive medicine market sat at $409.4B at year-end 2025, propelled by aging cohorts, chronic-disease prevalence, and mandates around routine screenings. Growth hinges on retail-clinic expansion and employer-sponsored wellness, as systems pivot from reactive treatment to proactive prevention.
The global electric vehicle battery market sat at $78B in 2025 and is forecast to reach $279B by 2036, compounding at 13.6% annually. CATL controls 35% of the sector, with BYD and LG Energy Solution trailing at 16% and 14% respectively.
The interventional cardiology market sat at $18.5B at year-end 2025 and is tracking to $36.1B by 2036—a 6.9% compound. Grand View Research and Precedence Research both peg the expansion to aging populations in North America and Europe plus the shift from open-heart surgery to catheter-based procedures.
The parametric insurance market closed 2025 at $16.5B. Allied Market Research and Mordor Intelligence peg the 2036 exit at $42B, a 9.8% compound.
The industrial centrifuge market closed 2025 at $8.2B, with Alfa Laval and GEA holding a combined 31% across decanter, disk-stack, and tubular segments. We're tracking accelerated wastewater capex in China and India driving decanter demand, offset by margin pressure as second-tier European OEMs cut pricing 6-9% to defend share against Asian entrants.
The global electric vehicle inverter market sat at $6.68B at year-end 2025. Battery-electric and plug-in hybrid adoption is pulling silicon carbide inverters into volume production, though margin pressure from commoditisation already shows in the 2024 numbers.
The global hydrodesulfurization catalyst market sat at $4,435M in 2025, pulled forward by ultra-low sulfur mandates in transportation fuels across OECD and emerging economies. Refinery capacity expansions in Asia Pacific and the shift to cleaner fuel specs continue to lift demand for CoMo and NiMo catalyst formulations.
The affinity chromatography market closed 2025 at $4.2B and is forecast to reach $9.1B by 2036, compounding at 7.9%. Cytiva holds 25% share at ~$1.1B sector revenue, followed by Thermo Fisher at 20% and Merck KGaA at 15%.
The neurovascular devices market closed 2025 at $4.2B and is tracking toward $10.2B by 2036, a 9.3% CAGR that makes it the fastest-expanding slice of interventional medicine. Thrombectomy devices hold 38% of the mix, coils 25%, and flow diverters 22%.
The semiconductor waste gas abatement systems market closed 2025 at $8.4B, with Edwards Vacuum holding 22% share by our count after the Atlas Copco integration streamlined POU combustion unit shipments in Q3. We're tracking abatement attach rates climbing to 94% on leading-edge EUV litho tools versus 78% industry-wide, driven by tightening PFC emission caps in EU and Taiwan that took effect January 2025.
The global thrombus aspiration catheter market reached $1,960M in 2025, anchored by rising acute coronary syndrome and stroke presentations that demand mechanical thrombectomy. Hospitals are replacing pharmacological thrombolysis with manual and power-assisted aspiration systems in percutaneous coronary intervention and neurovascular workflows.
The global thrombectomy devices market sat at $1,940M in 2025, anchored by acute ischemic stroke protocols and the shift to mechanical intervention over pharmacological thrombolysis. We're tracking a 7.2% CAGR through 2036 to $3,892M, paced by stent-retriever refinements and aspiration-catheter adoption in complete stroke centers.
The solid-state battery market closed 2025 at $1.2B and is on track to hit $18.1B by 2036, compounding at 31.2% annually. Toyota holds 20% of current sector revenue at $240M, with Samsung SDI at 15% and a cluster of venture-backed entrants fighting for the next 5%.
The global veterinary urinalysis market sat at $1,100M in 2025, expanding on the back of rising pet ownership and preventive-care adoption across developed markets. Growth is tied to point-of-care automation and the normalization of routine wellness screening in companion animal diagnostics.
30 chapters of validated intelligence. Here is what you get.
Commission a custom intelligence report. 30 chapters, 26 data sources, accessible instantly on demand.
The global Inpatient Services market is valued at $2.1T in 2026, with a projected CAGR of 3.4% through 2036. Growth is driven by accelerating adoption mandates, declining costs, and expanding capacity.
| Company | HQ | Share |
|---|---|---|
| HCA Healthcare | United States | 3.6% |
| UnitedHealth Group (Optum Health) | United States | 3.3% |
| Fresenius Helios | Germany | 2% |
| CommonSpirit Health | United States | 1.7% |
Markets
Methodology
About
Research leadership